Navigation Links
UTSA receives $1.2 million gift from Kleberg Foundation
Date:1/23/2009

San Antonio Officials with The University of Texas at San Antonio (UTSA) today announced receipt of a $1.2 million gift from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation that will be used to purchase a second generation aberration corrected electron microscope. The instrument, one of only two worldwide, will help nanotechnology researchers develop new cancer therapies and treatments that combat a variety of human diseases. The microscope is not just for UTSA. It will be available to scientists across the globe and across many disciplines to advance research in their respective fields.

"We are extraordinarily grateful to the Kleberg Foundation for its support of UTSA," said Ricardo Romo, UTSA's president. "This gift will put UTSA and nanotechnology research on the map at a time when UTSA hopes to become a Top-100 research university."

"The board of the Richard J. Kleberg, Jr. and Helen C. Kleberg Foundation is very happy to be a contributor to UTSA and the progress that is going forward at the university, progress that will be a benefit to the community, state, country and the world at large," said Helen K. Groves, foundation president.

UTSA will house its new microscope, manufactured by industry leader JEOL USA, in its Advanced Microscopy Laboratory under the supervision of world-renowned researcher Miguel Yacaman, chair of the College of Sciences' Department of Physics and Astronomy. There, it will support first-class research in nanotechnology, materials science, medicine, biology, chemistry and engineering, allowing scientists to view images at a resolution of less than one Angstrom (10^-10 meters).

"Our global team understands the significance of UTSA's broad vision, and we are committed to providing JEOL's premier technology and applications support to help them achieve their goals," said Pete Genovese, JEOL's vice president and general manager, sales and marketing.

Tom Isabell, JEOL's TEM product manager, materials science, added, "The selection of this new, extraordinary microscope will provide collaborating research scientists with a unique gateway to study and share their experiences and knowledge about atomic properties - in action - at the nanoscale."

"This microscope will open up the world of science to researchers at the atomic level much the same way that telescopes such as the Hubble opened up the universe to astronomers," said Yacaman.

UTSA's microscope is slated for installation in October 2009. The instrument takes six months to fabricate and three months to install. Once up and running, researchers from across the world can send samples to UTSA, then through remote access, conduct experiments without leaving their home laboratories.


'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
210-458-7584
University of Texas at San Antonio
Source:Eurekalert

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Salt Lake City, Utah (PRWEB) , ... August 16, 2017 , ... ... its spot on the Inc 5000 list for the fourth consecutive year. ... the Inc. 5000 2017 list of the nation’s fastest growing companies. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... to patients suffering from chronic pelvic pain. In addition to oncology services, ... pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine fibroids, and ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... awards program which recognizes organizations that demonstrate the core values of business innovation, ... categories. , “As a global company, we are expanding our presence in all ...
(Date:8/16/2017)... ... , ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen F. ... an insatiable appetite for God’s Word. , “I froze between the half walls, shelves on ... of oatmeal. I have one to this day on proud display in my dining room ...
(Date:8/15/2017)... ... ... city of Los Angeles is a west coast style fashion center as well as a ... website that spotlights fashion news from Los Angeles and around the world, is sharing clothing ... to the senior editor of latsl.com , “For a business that is known for ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics ... Dallas, Texas , has received notice from ... National Institutes of Health (NIH) that it has been ... grant totaling over $650,000 in 2017 with an additional ... CerSci,s Investigational New Drug application of their lead non-opioid ...
Breaking Medicine Technology: